Serum levels of inflammatory markers in depressed elderly patients with diabetes and mild cognitive impairment

PLoS ONE

Volumn 10, Issue 3, 2015, Pages

  Gorska Ciebiada, Malgorzata ^a   Saryusz Wolska, Malgorzata ^a   Borkowska, Anna ^a   Ciebiada, Maciej ^a   Loba, Jerzy ^a  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; HEMOGLOBIN A1C; INSULIN; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA; BIOLOGICAL MARKER; GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN A1C PROTEIN, HUMAN; TUMOR NECROSIS FACTOR;

AGED; ARTICLE; BODY MASS; COMORBIDITY; CONTROLLED STUDY; CORRELATIONAL STUDY; DEPRESSION; DIABETES MELLITUS; DIABETIC NEUROPATHY; DIABETIC RETINOPATHY; DISEASE ASSOCIATION; DISEASE DURATION; FEMALE; GERIATRIC DEPRESSION SCALE; GERIATRIC PATIENT; HUMAN; HYPERLIPIDEMIA; HYPOGLYCEMIA; INFLAMMATION; INSULIN TREATMENT; MAJOR CLINICAL STUDY; MALE; MILD COGNITIVE IMPAIRMENT; PHYSICAL ACTIVITY; PROTEIN BLOOD LEVEL; RISK FACTOR; SEX DIFFERENCE; SMOKING; BLOOD; CASE CONTROL STUDY; COGNITIVE DEFECT; COMPLICATION; METABOLISM; NON INSULIN DEPENDENT DIABETES MELLITUS;

AGED; BIOMARKERS; C-REACTIVE PROTEIN; CASE-CONTROL STUDIES; COGNITIVE DYSFUNCTION; DEPRESSION; DIABETES MELLITUS, TYPE 2; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; INFLAMMATION; INTERLEUKIN-6; MALE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84925652667     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0120433     Document Type: Article

References (53)

1. Luchsinger JA, Reitz C, Patel B, Tang MX, Manly JJ, Mayeux R. Relation of diabetes to mild cognitive impairment. Arch Neurol. 2007; 64: 570-575. PMID: 17420320
2. Nouwen A, Winkley K, Twisk J, Lloyd CE, Peyrot M, Ismail K, et al. Type 2 diabetes mellitus as a risk factor for the onset of depression: a systematic review and meta-analysis. Diabetologia. 2010; 53: 2480-2486. doi: 10.1007/s00125-010-1874-x PMID: 20711716
3. Panza F, Frisardi V, Capurso C, D'Introno A, Colacicco AM, Imbimbo BP, et al. Late life depression, mild cognitive impairment, and dementia: possible continuum? Am J Geriatr Psychiatry. 2010; 18: 98-116. doi: 10.1097/JGP.0b013e3181b0fa13 PMID: 20104067
4. Hidaka S, Ikejima C, Kodama C, Nose M, Yamashita F, Nose M, et al. Prevalence of depression and depressive symptoms among older Japanese people: comorbidity of mild cognitive impairment and depression. Int J Geriatr Psychiatry. 2012; 27: 271-279. doi: 10.1002/gps.2715 PMID: 21448864
5. Gorska-Ciebiada M, Saryusz-Wolska M, Ciebiada M, Loba J. Mild cognitive impairment and depressive symptoms in elderly patients with diabetes- prevalence, risk factors and co-morbidity. J Diabetes Res. 2014 Nov 9: 179648. doi: 10.1155/2014/179648
6. Alexopoulos GS. The vascular depression hypothesis: 10 years later. Biol Psychiatry. 2006; 60: 1304-1305. PMID: 17157096
7. Umegaki H, Kawamura T, Kawano N, Umemura T, Kanai A, Sano T. Factors associated with cognitive decline in elderly diabetics. Dement Geriatr Cogn Disord Extra. 2011; 1: 1-9. doi: 10.1159/000323188
8. Barnes DE, Alexopoulos GS, Lopez OL, Williamson JD, Yaffe K. Depressive symptoms, vascular disease, and mild cognitive impairment findings from the Cardiovascular Health Study. Arch Gen Psychiatry. 2006; 63: 273-279. PMID: 16520432
9. Hermida AP, McDonald WM, Steenland K, Levey A. The association between late-life depression, mild cognitive impairment and dementia: is inflammation the missing link? Expert Rev Neurother. 2012; 12: 1339-1350. doi: 10.1586/ern.12.127 PMID: 23234395
10. Pizzi C, Manzoli L, Mancini S, Costa GM. Analysis of potential predictors of depression among coronary heart disease risk factors including heart rate variability, markers of inflammation, and endothelial function. European Heart Journal 2008; 29: 1110-1117. doi: 10.1093/eurheartj/ehn137 PMID: 18400765
11. Dowlati Y, Herrmann N, Swardfager W, Liu H, Sham L, Reim EK, et al. A meta-analysis of cytokines in major depression. Biol Psychiatry. 2010; 67: 446-457. doi: 10.1016/j.biopsych.2009.09.033 PMID: 20015486
12. Howren MB, Lamkin DM, Suls J. Associations of depression with C-reactive protein, IL-1, and IL-6: a meta-analysis. Psychosom Med. 2009; 71: 171-186. doi: 10.1097/PSY.0b013e3181907c1b PMID: 19188531
13. Yaffe K, Lindquist K, Penninx BW, Simonsick EM, Pahor M, Kritchevsky S, et al. Inflammatory markers and cognition in well-functioning African-American and white elders. Neurology. 2003; 61: 76-80. PMID: 12847160
14. Dinan TG. Inflammatory markers in depression. Curr Opin Psychiatry 2009; 2: 32-36. doi: 10.1097/YCO.0b013e328315a561
15. Iosif RE, Ekdahl CT, Ahlenius H, Pronk CJ, Bonde S, Kokaia Z, et al. Tumor necrosis factor receptor 1 is a negative regulator of progenitor proliferation in adult hippocampal neurogenesis. J Neurosci. 2006; 26: 9703-9712. PMID: 16988041
16. Monje ML, Toda H, Palmer TD. Inflammatory blockade restores adult hippocampal neurogenesis. Science. 2003; 302: 1760-1765. PMID: 14615545
17. Dowlati Y, Herrmann N, Swardfager W, Liu H, Sham L, Reim EK, et al. A meta-analysis of cytokines in major depression. Biol Psychiatry. 2010; 67: 446-457. doi: 10.1016/j.biopsych.2009.09.033 PMID: 20015486
18. Kahl KG, Bens S, Ziegler K, Rudolf S, Dibbelt L, Kordon A, et al. Cortisol, the cortisol-dehydroepian-drosterone ratio, and pro-inflammatory cytokines in patients with current major depressive disorder comorbid with borderline personality disorder. Biol Psychiatry. 2006; 59: 667-671. PMID: 16199015
19. Raison CL, Capuron L, Miller AH. Cytokines sing the blues: inflammation and the pathogenesis of depression. Trends Immunol 2006; 27: 24-31. PMID: 16316783
20. Steptoe A, Hamer M, Chida Y. The effects of acute psychological stress on circulating inflammatory factors in humans: a review and meta-analysis. Brain Behav Immun. 2007; 21: 901-912. PMID: 17475444
21. Gimeno D, Kivimäki M, Brunner EJ, Elovainio M, De Vogli R, Steptoe A, et al. Associations of C-reactive protein and interleukin-6 with cognitive symptoms of depression: 12-year follow-up of the Whitehall II study. Psychol Med. 2009; 39: 413-423. doi: 10.1017/S0033291708003723 PMID: 18533059
22. Robertsa RO, Gedaa YE, Knopmanc DS, Boeve BF, Christabson TJ, Pankratz VS, et al. Association of C-reactive protein with mild cognitive impairment. Alzheimers Dement. 2009; 5: 398-405. doi: 10.1016/j.jalz.2009.01.025 PMID: 19751919
23. Trollor JN, Smith E, Baune BT, Kochan NA, Campbell L, Samaras K, et al. Systemic inflammation is associated with MCI and its subtypes: The Sydney Memory and Aging Study. Dement Geriatr Cogn Disord. 2010; 30: 569-578. doi: 10.1159/000322092 PMID: 21252552
24. Nasreddine ZS, Phillips NA, Bédirian V, Charbonneau S, Whitehead V, Collin I, et al. The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc. 2005; 53: 695-699. PMID: 15817019
25. Yesavage J, Brink T, Rose T, Lum O, Huang V, Adev M, et al. Development and validation of a geriatric depression screening scale: a preliminary report. J Psychiatr Res. 1982-1983; 17: 37-49.
26. Katz S, Downs TD, Cash HR, Grotz RC. Progress in development of the index of ADL. Gerontologist. 1970; 10: 20-30. PMID: 5420677
27. Lawton MP, Brody EM. Assessment of older people: self-maintaining and instrumental activities of daily living. Gerontologist. 1969; 9: 179-186. PMID: 5349366
28. Alagiakrishnan K, Zhao N, Mereu L, Senior P, Senthilselvan A. Montreal Cognitive Assessment is superior to standardized Mini-Mental Status Exam in detecting Mild Cognitive Impairment in the middle-aged and elderly patients with type 2 diabetes mellitus. Biomed Res Int. 2013 Jul 11: 186106. doi: 10.1155/2013/186106 PMID: 23936778
29. Petersen RC. Mild cognitive impairment as a diagnostic entity. Journal of Internal Medicine. 2004; 256: 183-194. PMID: 15324362
30. Portet F, Ousset PJ, Visser PJ, Frisoni GB, Nobili F, Scheltens P, et al. Mild cognitive impairment (MCI) in medical practice: a critical review of the concept and new diagnostic procedure. Report of the MCI Working Group of the European Consortium on Alzheimer's Disease. Journal of Neurol Neurosurg Psychiatry. 2006; 77: 714-718. PMID: 16549412
31. de Groot M, Anderson R, Freedland KE, Clouse RE, Lustman PJ. Association of depression and diabetes complications: a meta-analysis. Psychosom Med. 2001; 63: 619-630. PMID: 11485116
32. Stuart MJ, Baune BT. Depression and type 2 diabetes: Inflammatory mechanisms of a psychoneuroendocrine co-morbidity. Neuroscience and Biobehavioral Reviews. 2012; 36: 658-676. doi: 10.1016/j.neubiorev.2011.10.001 PMID: 22020230
33. Doyle TA, de Groot M, Harris T, Schwartz F, Strotmeyer ES, Johnson KC, et al. Diabetes, depressive symptoms, and inflammation in older adults: Results from the Health, Aging, and Body Composition Study. J Psychosom Res. 2013; 75: 419-424. doi: 10.1016/j.jpsychores.2013.08.006 PMID: 24182629
34. Danner M, Kasl SV, Abramson JL, Vaccarino V. Association between depression and elevated C-reactive protein. Psychosom Med. 2003; 65: 347-356. PMID: 12764206
35. Ford DE, Erlinger TP. Depression and C-reactive protein in US adults: data from the Third National Health and Nutrition Examination Survey. Arch Intern Med. 2004; 164: 1010-1014. PMID: 15136311
36. Quan N, Banks WA. Brain-immune communication pathways. Brain Behav Immun. 2007; 21: 727-735. PMID: 17604598
37. Banks WA, Kastin AJ, Ehrensing CA. Diurnal uptake of circulating interleukin-1alpha by brain, spinal cord, testis and muscle. Neuroimmunomodulation. 1998; 5: 36-41. PMID: 9698256
38. Leonard BE. Inflammation, depression and dementia: are they connected? Neurochem Res. 2007; 32: 1749-1756. PMID: 17705097
39. Ding J, Strachan MW, Reynolds RM, Frier BM, Deary IJ, Fowkes FG, et al. Diabetic retinopathy and cognitive decline in older people with type 2 diabetes: the Edinburgh type 2 diabetes study. Diabetes. 2010; 59: 2883-2889. doi: 10.2337/db10-0752 PMID: 20798334
40. Akiyama H, Barger S, Barnum S, Bradt B, Bauer J, Cole GM, et al. Inflammation and Alzheimer's disease. Neurobiol Aging. 2000; 21: 383-421. PMID: 10858586
41. Tiemeier H, van Dijck W, Hofman A, Witteman JC, Stijnen T, Breteler MM. Relationship between atherosclerosis and late-life depression: the Rotterdam Study. Arch Gen Psychiatry. 2004; 61: 369-376. PMID: 15066895
42. Elovainio M, Keltikangas-Järvinen L, Kivimäki M, Pulkki L, Puttonen S, Heponiemi T, et al. Depressive symptoms and carotid artery intima-media thickness in young adults: the Cardiovascular Risk in Young Finns Study. Psychosom Med. 2005; 67: 561-567. PMID: 16046368
43. Faramawi MF, Gustat J, Wildman RP, Rice J, Johnson E, Sherwin R. Cardiovascular Health Study Investigators. Relation between depressive symptoms and common carotid artery atherosclerosis in American persons > or = 65 years of age. Am J Cardiol. 2007; 99: 1610-1613. PMID: 17531591
44. Whipple MO, Lewis TT, Sutton-Tyrrell K, Matthews KA, Barinas-Mitchell E, Powell LH, et al. Hopelessness, depressive symptoms, and carotid atherosclerosis in women: the Study of Women's Health Across the Nation (SWAN) heart study. Stroke. 2009; 40: 3166-3172. doi: 10.1161/STROKEAHA.109.554519 PMID: 19713542
45. Camus V, Kraehenbühl H, Preisig M, Büla CJ, Waeber G. Geriatric depression and vascular diseases: what are the links? J. Affect. Disord 2004; 81: 1-16. PMID: 15183594
46. Jellinger KA. Pathology and pathogenesis of vascular cognitive impairment - a critical update. Front Aging Neurosci. 2013; 5: 17. doi: 10.3389/fnagi.2013.00017 PMID: 23596414
47. Tousoulis D, Papageorgiou N, Androulakis E, Siasos G, Latsios G, Tentolouris K, et al. Diabetes Mellitus- Associated Vascular Impairment Novel Circulating Biomarkers and Therapeutic Approaches. J Am Coll Cardiol 2013; 62: 667-676. doi: 10.1016/j.jacc.2013.03.089 PMID: 23948511
48. Empana JP, Sykes DH, Luc G, Juhan-Vague I, Arveiler D, Ferrieres J, et al. Contributions of depressive mood and circulating inflammatory markers to coronary heart disease in healthy European men: the prospective epidemiological study of myocardial infarction (PRIME). Circulation 2005; 111: 2299-2305. PMID: 15867179
49. Ladwig K, Marten-Mittag B, Lowel H, Doring A, Koenig W. C-reactive protein, depressed mood, and the prediction of coronary heart disease in initially healthy men: results from the MONICA-KORA Augsburg Cohort Study 1984-1998. Eur Heart J. 2005; 26: 2537-2542. PMID: 16126719
50. Ferketich AK, Ferguson JP, Binkley PF. Depressive symptoms and inflammation among heart failure patients. Am Heart J. 2005; 150: 132-6. PMID: 16084159
51. Miller GE, Freedland KE, Duntley S, Carney RM. Relation of depressive symptoms to C-reactive protein and pathogen burden (cytomegalovirus, herpes simplex virus, Epstein-Barr virus) in patients with earlier acute coronary syndromes. Am J Cardiol. 2005; 95: 317-321. PMID: 15670537
52. Rutter MK, Meigs JB, Sullivan LM, D 'Agostino RB, Wilson PW, et al. Insulin resistance, the metabolic syndrome, and incident cardiovascular events in the Framingham Offspring Study. Diabetes 2005; 54: 3252-3257. PMID: 16249452
53. Roberts RO, Geda YE, Knopman DS, Cha RH, Boeve BF, Ivnik RJ, et al. Metabolic syndrome, inflammation, and nonamnestic mild cognitive impairment in older persons: a population-based study. Alzheimer Dis Assoc Disord. 2010; 24: 11-18. doi: 10.1097/WAD.0b013e3181a4485c PMID: 19568151